Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fifth Affiliated Hospital of Guangzhou Medical University | OTHER |
Not provided
Not provided
Not provided
Not provided
Lycium barbarum, a traditional Chinese herbal medicine, is a commonly used herb in the traditional Chinese pharmacopoeia. Its main active ingredient, lycium barbarum polysaccharide (LBP), is reported to have neuroprotective effects. Animal studies suggested that LBP has neuroprotective effect on optic ganglion cells. In animal models of depression, LBP can improve depressive symptom by improving synaptic plasticity. However, its clinical effect remains to be studied. We will conduct a 6-week double-blind, randomized, placebo-con-trolled trial in patients with major depressive disorder (MDD). The purpose of this clinical trial is to investigate the efficacy of LBP in patients with MDD.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lycium barbarum polysaccharide | Experimental | Experimental group takes Lycium barbarum polysaccharide (LBP) tablet (300mg/day) for 6 weeks |
|
| Placebo | Placebo Comparator | Placebo control group takes placebo (300mg/day) for 6 weeks. The placebos are the same with the LBP tablets in appearance and taste. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lycium barbarum polysaccharide | Dietary Supplement | Experimental groups take Lycium barbarum polysaccharide (LBP) (300mg/day) for 6 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Reduction rate of Hamilton Depression Scale (HDRS) | HDRS is used to measure the depressive severity；its measured time range is within the past week. In this study, version of 24-items is used. The patients are depressed when the total score are greater than 19 points, and there are no depression when the total scores are less than points. Clinical control, HDRS score reduction rate≥75%; significant progress, 50%≤HDRS score reduction rate < 75%; progress, 25%≤HDRS score reduction rate < 50%; ineffectiveness, HDRS score reduction rate < 25%. significant efficiency = (clinical control + significant progress) / sample number×100%. | 4weeks, 6weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in depressive severity measured by Beck Depression Inventory (BDI) scale and Kessler Scale(K10) | BDI scale is used to measure depressive severity by patients themselves. It's made of 21 items. Circle the number in front of the sentence that best suits your situation in according to the feeling for a week. The total score is obtained by adding up the delimited scores of each item. There is depression when the total score is greater than 15 points and there is no depression when the total score is less than 10 points. The K10 is a widely used, simple self-report measure of psychological distress which can be used to identify those in need of further assessment of depression and anxiety |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kangguang Lin, MD, PhD | Contact | 13560360144 | klin@connect.hku.hk |
| Name | Affiliation | Role |
|---|---|---|
| Kangguang Lin, MD, PhD | Guangzhou Brain Hospital (Guangzhou Huiai Hospital) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Guangzhou Brain Hospital (Guangzhou Huiai Hospital) | Recruiting | Guanzhou | Guangdong | 510370 | China |
Not provided
| ID | Term |
|---|---|
| D003865 | Depressive Disorder, Major |
| D003863 | Depression |
| D003866 | Depressive Disorder |
| ID | Term |
|---|---|
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| C500223 | lycium barbarum polysaccharide |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Dietary Supplement | Placebo control group takes placebo (300mg/day) for 6 weeks. |
|
| 4 weeks, 6 weeks |
| Changes in sleep quality | Changes in Pittsburgh Sleep Quality Index (PSQI) scale. PSQI scale is used to evaluate sleep quality for last month. It's made of 7 items; every item is scored 1-4 point. Total score is obtained by adding up the points of 7 items. Total score range is 0~21 point. The sleep quality is worse when the total score is higher. | 4 weeks, 6 weeks |
| Changes in cognitive function | Cognitive function is assessed using the THINC-it. The THINC-it was recently developed by the THINC-it Task Force (http://thinc.progress.im/en) with the principal goal of time-efficient screening of cognitive impairments specifically among individuals with major depressive disorder as a routine component of their clinical care. THINC-it is a digitized cognitive assessment battery comprised of carefully selected gamified variations of well-known cognitive tasks (Spotter [Choice Reaction Time], Symbol Check [One-Back], Codebreaker [Digit Symbol Substitution Test], Trails [Trail Making Test-Part B]), and the Perceived Deficits Questionnaire for Depression-5-item (PDQ-5-D), a subjective self-report scale. | 4 weeks, 6 weeks |
| Changes in social adaptive levels | Measured by Global Assessment Function (GAF) scale. GAF scale is used to evaluate the condition and social adaptability in psychiatry patients. It's divided into 1 to 100 grades. The lower the score, the more serious the disease is. 91-100 points shows that the patients have good social adaptation and normal mental status. | 4 weeks, 6 weeks |
| Changes in serum brain-derived neurotrophic factor (BDNF) levels | We measure the serum BDNF levels by enzyme linked immunosorbent assay (ELISA) | 6 weeks |
| Changes in serum triglyceride levels | The blood of patients are sent to clinical laboratory of our hospital to measure serum triglyceride levels | 6 weeks |
| Changes in serum total cholesterol levels | The blood of patients are sent to clinical laboratory of our hospital to measure serum total cholesterol levels | 6 weeks |